Additionally, as biopsy is performed using a single-puncture technique and focused on the most PSMA-avid lesion, tumors with negative or low PSMA expression might be missed by PSMA PET, although this circumstance represents only a small percentage of prostate cancer at primary diagnosis (i.e., 5%) [59,60]. The gene discussed is FOLH1; the disease is prostate carcinoma.